Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab + Chemotherapy in NSCLC with Brain Metastases
NCT01951482Phase 3Completed
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2016
- Primary completion
- Dec 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC), sponsored by Sun Yat-sen University. Started Jan 2016; status: completed.
02
Drugs
bevacizumab
03
Conditions
Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC)
Beyond the preview
Go deeper on NCT01951482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01951482.